NYSE · DOLE
Dole plc
$13.15+$0.01 (+0.08%)
Dole plc’s quoted price sits in the lower half of its reported 52-week range, 20.64% below the high.
Loading market information…
NYSE · CANO · USD
Stock price, earnings
Quote as of Feb 2, 2024, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Cano Health, Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.79% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Cano Health, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Cano Health, Inc. delivers primary healthcare services to individuals across the United States and Puerto Rico. The company manages and runs medical facilities that leverage CanoPanorama, its exclusive population health management technology platform. This platform offers healthcare providers a comprehensive overview of their patients, along with practical data to enhance treatment choices and patient involvement. Furthermore, Cano Health operates pharmacies and provides dental care within its medical centers. By December 31, 2021, the firm had established 130 owned medical centers and partnered with around 1,000 affiliated providers, catering to approximately 227,005 members. Established in 2009, Cano Health, Inc. is headquartered in Miami, Florida.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:26 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2022 | Aug 9, 2022 | -$3.00+25.0% vs estimate | $689.37M |
|---|
| Q1 2022 | May 9, 2022 | -$7.00+30.0% vs estimate | $704.34M+5.75% vs estimate |
|---|
THE ANALYST VIEW
10 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$13.15+$0.01 (+0.08%)
Dole plc’s quoted price sits in the lower half of its reported 52-week range, 20.64% below the high.
$2.06+$0.07 (+3.52%)
TuHURA Biosciences, Inc.’s quoted price sits in the upper half of its reported 52-week range, 39.94% below the high.
$0.61+$0.61 (+100.0%)
23andMe Holding Co.’s quoted price sits in the lower half of its reported 52-week range, 95.25% below the high.
$4.58$0.00 (0.0%)
Axcella Health Inc.: Healthcare · Biotechnology.
$0.84+$0.01 (+1.07%)
Field Trip Health Ltd.: Healthcare · Medical - Care Facilities.
$2.03-$0.17 (-7.73%)
DataMEDS AI, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.03% below the high.
$0.25-$0.09 (-27.68%)
Notable Labs, Ltd.’s quoted price sits in the lower half of its reported 52-week range, 94.15% below the high.
$0.02$0.00 (0.0%)
SQZ Biotechnologies Company’s quoted price sits in the lower half of its reported 52-week range, 65.71% below the high.
